Latest news with #MTL
Cision Canada
14 hours ago
- Business
- Cision Canada
MTL Cannabis Corp. Announces Upgrade to OTCQX Français
PICKERING, ON, June 10, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) ("MTL" or the "Company") is pleased to announce that it has qualified to upgrade from the OTCQB ® Venture Market to the OTCQX ® Best Market (the "OTCQX Market" or "OTCQX"). MTL Cannabis Corp. will commence trading today on OTCQX under the symbol "MTLNF". The OTCQX Market, the highest level of the U.S. OTC Markets, is designed for established, investor-focused U.S. and international companies. Trading on OTCQX is expected to enhance a company's visibility and accessibility among U.S. investors by adhering to higher financial and governance standards. "We are pleased to be upgrading to the OTCQX market. We feel that OTCQX will provide a valuable platform to help build visibility among U.S. investors," said Michael Perron, CEO of MTL Cannabis Corp. The Company's common shares will continue to trade on the Canadian Securities Exchange in Canada under the symbol "MTLC". About MTL Cannabis Corp. MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. ("MTL Cannabis"), a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis. It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services. For further information, please visit or the Company's public filings at Cautionary Statement Regarding Forward-Looking Information. This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
Cision Canada
4 days ago
- Business
- Cision Canada
MTL Cannabis Corp. Announces Shareholder Alignment Initiative
PICKERING, ON, June 6, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") announced today its shareholder alignment initiatives through the implementation of a long-term incentive plan ("LTIP"). In connection with the approval of the LTIP, executive officers were granted restricted share units ("RSUs") and deferred share units ("DSUs"), with deferred vesting. This initiative reflects the Company's commitment to aligning the executive team interests with shareholders and to support retention and leadership stability. The grant was comprised of two million RSUs and three million DSUs, with the RSUs vesting annually in arrears over three years and the DSUs vesting on the third anniversary of the grant. About MTL Cannabis Corp. MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. ("MTL Cannabis"), a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis. It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services. For further information, please visit or the Company's public filings at Cautionary Statement Regarding Forward-Looking Information. This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
Yahoo
4 days ago
- Business
- Yahoo
MTL Cannabis Corp. Announces Shareholder Alignment Initiative
PICKERING, ON, June 6, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") announced today its shareholder alignment initiatives through the implementation of a long-term incentive plan ("LTIP"). In connection with the approval of the LTIP, executive officers were granted restricted share units ("RSUs") and deferred share units ("DSUs"), with deferred vesting. This initiative reflects the Company's commitment to aligning the executive team interests with shareholders and to support retention and leadership stability. The grant was comprised of two million RSUs and three million DSUs, with the RSUs vesting annually in arrears over three years and the DSUs vesting on the third anniversary of the grant. About MTL Cannabis Corp. MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. ("MTL Cannabis"), a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis. It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services. For further information, please visit or the Company's public filings at Cautionary Statement Regarding Forward-Looking Information. This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law. Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. SOURCE MTL Cannabis Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Star
6 days ago
- Business
- The Star
Econpile unit accepts RM42.82mil job for Penang LRT project
KUALA LUMPUR: Econpile Holdings Bhd said its subsidiary Econpile (M) Sdn Bhd has accepted a contract from Irama Duta Sdn Bhd to undertake bored piling construction and other associated works from East Jelutong to Gelugor for a light rail transit (LRT) project for RM42.82mil. In a statement, the group said the project comes under Sub-Package BP06 for Projek Rapid Transit Aliran Ringan (LRT) Pulau Pinang – Laluan Mutiara (MTL) – Package CMC1. The project commences on Aug 1, 2025, and has a practical completion date of Oct 31, 2027. The project is expected to contribute positively to the revenue and earnings of the Company from the financial year ending June 30, 2026, onward.
Yahoo
29-05-2025
- Business
- Yahoo
Yeahka Obtains MTL Payment License in U.S., Accelerating Its Globalization Strategy
Yeahka has once again obtained a significant payment license. HONG KONG, May 29, 2025 /PRNewswire/ -- Recently, Yeahka ( a leading payment-based technology platform, has been granted the Money Transmitter License (MTL) by the financial regulatory authorities in Arizona, USA. This marks another important milestone in Yeahka's journey towards globalization since obtaining the Money Services Business (MSB) license. Obtaining the MTL license in the United States requires a complex and time-consuming process, involving multiple procedures and rigorous evaluations. Typically, companies must firstly apply for the MSB license as a prerequisite before applying for MTL licenses in individual states to comply with local regulations. Yeahka's successful acquisition of the MTL license reflects the recognition of its products, compliance standards, and overall strength by U.S. financial regulators. With both MSB and MTL licenses in place, Yeahka can now offer secure, compliant, and efficient payment services to users, laying the foundation for further expansion in the American market. Overseas expansion has been a key focus for Yeahka in recent years. Since commencing its overseas market exploration in 2021, Yeahka has prioritized compliance, actively pursuing licenses in various regions, including the MSO in Hong Kong, MPI in Singapore, and MSB in the United States. It has launched services such as local wallets, overseas wallets, credit cards, joint acquiring, foreign exchange, and cross-border remittances, providing secure, convenient, and efficient digital financial services to customers worldwide. To accelerate market penetration and enhance customer loyalty, Yeahka has strengthened internal synergies while advancing its globalization strategy. This includes diversifying payment channels, efficient service delivery capabilities, and overseas investments, enabling the company to tap into new industries such as automotive, luxuries, beauty, and entertainment. Notable clients include Clinique, Arabica, Bose, and Leica Camera, among others, reflecting a more diversified client base and stronger business resilience. In 2024, Yeahka's overseas business experienced rapid growth. According to the latest financial data, the company's overseas transactions for the year exceeded RMB 1.1 billion, a five-fold increase year-over-year, showcasing its robust market expansion capabilities and customer recognition. View original content: SOURCE Yeahka Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
